Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under ...
In a bipartisan spending agreement that was largely negotiated behind closed doors, Congress included a policy change with ...
On March 17, 2026, the Ninth Circuit issued a unanimous decision in United States ex rel. Adventist Health Sys. of W. v. AbbVie Inc. allowing a ...
The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...
The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.
Add Yahoo as a preferred source to see more of our stories on Google. Photo: Shopify Partners / Burst (The Center Square) – Hospitals and clinics in Michigan participating in a federal drug discount ...
MedPage Today on MSN
Hospitals, Drugmakers, and U.S. Government Continue Battle Over 340B Program
The drug discount program is under scrutiny on a variety of fronts ...
There are times when more isn’t better. It’s just more. This is one of those times. Democratic legislators are pushing Senate Bill 5981, which would expand a little-known federal drug discount program ...
As the Trump administration prepares to force its Most Favored Nation price controls on drug makers, a major U.S. lobbying group is pushing for a change to drug discounts law that would necessitate a ...
(The Center Square) – Hospitals and clinics in Michigan participating in a federal drug discount program are marking up medications and shifting costs onto public employee health plans, according to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results